Mariani, . G., Guidi, . L. and Barioglio, . A. (2006) “Olanzapine versus typical neuroleptics for schizophrenia: evaluation of social and economic costs”, Farmeconomia. Health economics and therapeutic pathways, 7(2), pp. 119–124. doi: 10.7175/fe.v7i2.681.